InvestSMART

iShares MSCI Emerging Markets ETF (ASX: IEM) - Related Research

Current share price for IEM : $83.810 0.06 (0.07%)+

iShares MSCI Emerging Markets ETF (IEM) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. iShares MSCI Emerging Markets ETF (IEM) is an exchange traded fund seeking to provide investment results that correspond to the price and yield performance of publicly traded securities in emerging markets, as represented by the MSCI Emerging Markets Index (the Underlying Index). The fund is managed by BlackRock Fund Advisors.

InvestSMART's Custom Portfolios allows you to invest in iShares MSCI Emerging Markets ETF (ASX: IEM). Find out more.

No research was found for IEM but you can find our latest research below...

Foster's board should carry can for wine blunder

Finally recognising one of the more obvious corporate blunders of recent times, Foster’s is a step closer to realising the tremendous potential of its beer business. But the blame for the wine fiasco can’t all be laid on the CEO.


10 Jun 2008
·
Article comments

Macquarie prefs look tempting

Macquarie Group’s new convertible preference shares have some similarities with the recently issued Suncorp convertible prefs, but there’s also an important difference.


10 Jun 2008
·
Article comments

Globe looks over the edge

The recent half-year result gave some hope that Globe’s turnaround is on track. It had better be quick, though, because the brands will wither without greater investment.


10 Jun 2008
·
Article comments

Blackmores' unhealthy competition

Since the demise of Pan Pharmaceuticals in 2003, Blackmores has enjoyed unprecedented health. But it hasn’t gone unnoticed and there’s an array of competitors lining up to share in the wealth.


29 May 2008
·
Article comments

NIB under observation

NIB set pulses racing when it became the first private health insurer to list on the Australian Stock Exchange, but recent budget changes have put the stock in the emergency ward. Our diagnosis suggests opportunity.


23 May 2008
·
Article comments

The news on Fairfax and APN

Time heals many wounds, but not necessarily our reservations about the future for newspapers. Fairfax, in particular, has been working hard to distance itself from its iconic metropolitan titles, but it may not be enough.


22 May 2008
·
Article comments

6901 - 6925 of 14949 results

Page 277 of 598

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.